• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载脂蛋白在糖尿病和冠心病中与高密度脂蛋白的结构-功能关系。

Structure-function relationships of HDL in diabetes and coronary heart disease.

机构信息

Department of Biosystems Science and Engineering, Swiss Federal Institute of Technology in Zurich (ETH Zurich), Basel, Switzerland.

Swiss Institute of Bioinformatics (SIB), Basel, Switzerland.

出版信息

JCI Insight. 2020 Jan 16;5(1):131491. doi: 10.1172/jci.insight.131491.

DOI:10.1172/jci.insight.131491
PMID:31830004
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7030825/
Abstract

High-density lipoproteins (HDL) contain hundreds of lipid species and proteins and exert many potentially vasoprotective and antidiabetogenic activities on cells. To resolve structure-function-disease relationships of HDL, we characterized HDL of 51 healthy subjects and 98 patients with diabetes (T2DM), coronary heart disease (CHD), or both for protein and lipid composition, as well as functionality in 5 cell types. The integration of 40 clinical characteristics, 34 nuclear magnetic resonance (NMR) features, 182 proteins, 227 lipid species, and 12 functional read-outs by high-dimensional statistical modeling revealed, first, that CHD and T2DM are associated with different changes of HDL in size distribution, protein and lipid composition, and function. Second, different cellular functions of HDL are weakly correlated with each other and determined by different structural components. Cholesterol efflux capacity (CEC) was no proxy of other functions. Third, 3 potentially novel determinants of HDL function were identified and validated by the use of artificially reconstituted HDL, namely the sphingadienine-based sphingomyelin SM 42:3 and glycosylphosphatidylinositol-phospholipase D1 for the ability of HDL to inhibit starvation-induced apoptosis of human aortic endothelial cells and apolipoprotein F for the ability of HDL to promote maximal respiration of brown adipocytes.

摘要

高密度脂蛋白 (HDL) 含有数百种脂质和蛋白质,对细胞具有多种潜在的血管保护和抗糖尿病作用。为了阐明 HDL 的结构-功能-疾病关系,我们对 51 名健康受试者和 98 名糖尿病(T2DM)、冠心病(CHD)或两者均有的患者的 HDL 进行了蛋白质和脂质组成以及 5 种细胞类型功能的特征分析。通过高维统计建模,将 40 项临床特征、34 项核磁共振(NMR)特征、182 种蛋白质、227 种脂质和 12 种功能读数进行整合,结果首先表明,CHD 和 T2DM 与 HDL 大小分布、蛋白质和脂质组成以及功能的不同变化相关。其次,HDL 的不同细胞功能彼此弱相关,由不同的结构成分决定。胆固醇流出能力(CEC)不能作为其他功能的替代指标。第三,通过使用人工再构建的 HDL,鉴定并验证了 3 种潜在的 HDL 功能决定因素,即基于鞘氨醇的鞘磷脂 SM 42:3 和糖基磷脂酰肌醇-磷脂酶 D1 可抑制人主动脉内皮细胞饥饿诱导的细胞凋亡,载脂蛋白 F 可促进棕色脂肪细胞的最大呼吸能力。

相似文献

1
Structure-function relationships of HDL in diabetes and coronary heart disease.载脂蛋白在糖尿病和冠心病中与高密度脂蛋白的结构-功能关系。
JCI Insight. 2020 Jan 16;5(1):131491. doi: 10.1172/jci.insight.131491.
2
Early Signs of Atherogenic Features in the HDL Lipidomes of Normolipidemic Patients Newly Diagnosed with Type 2 Diabetes.新诊断为 2 型糖尿病的正常脂质血症患者的高密度脂蛋白脂质组中动脉粥样硬化特征的早期迹象。
Int J Mol Sci. 2020 Nov 22;21(22):8835. doi: 10.3390/ijms21228835.
3
High-density lipoprotein in diabetes: Structural and functional relevance.糖尿病中的高密度脂蛋白:结构与功能相关性。
J Diabetes Investig. 2024 Jul;15(7):805-816. doi: 10.1111/jdi.14172. Epub 2024 Feb 28.
4
High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease.糖尿病、炎症与心血管疾病交叉领域中的高密度脂蛋白
Curr Opin Lipidol. 2004 Jun;15(3):269-78. doi: 10.1097/00041433-200406000-00006.
5
NMR-based lipidomic analysis of blood lipoproteins differentiates the progression of coronary heart disease.基于核磁共振的血液脂蛋白脂质组学分析可区分冠心病的进展情况。
J Proteome Res. 2014 May 2;13(5):2585-98. doi: 10.1021/pr500061n. Epub 2014 Apr 14.
6
The dual nature of HDL: Anti-Inflammatory and pro-Inflammatory.高密度脂蛋白的双重性质:抗炎和促炎。
Biofactors. 2015 May 6;41(3):153-9. doi: 10.1002/biof.1205. Epub 2015 Jun 13.
7
High density lipoproteins, diabetes and diabetic macrovascular disease.高密度脂蛋白、糖尿病与糖尿病大血管病变
Diabet Med. 1985 Sep;2(5):348-51. doi: 10.1111/j.1464-5491.1985.tb00648.x.
8
Diabetes Impairs Cellular Cholesterol Efflux From ABCA1 to Small HDL Particles.糖尿病损害细胞内胆固醇从ABCA1向小HDL颗粒的流出。
Circ Res. 2020 Oct 9;127(9):1198-1210. doi: 10.1161/CIRCRESAHA.120.317178. Epub 2020 Aug 21.
9
Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides.对氧磷酶-1的糖基化作用会抑制其活性,并损害高密度脂蛋白代谢膜脂质氢过氧化物的能力。
Diabet Med. 2008 Sep;25(9):1049-55. doi: 10.1111/j.1464-5491.2008.02546.x.
10
Therapeutic applications of reconstituted HDL: When structure meets function.载脂蛋白 A-I 介导的 HDL 重构:结构与功能的相遇
Pharmacol Ther. 2016 Jan;157:28-42. doi: 10.1016/j.pharmthera.2015.10.010. Epub 2015 Nov 10.

引用本文的文献

1
High-density lipoproteins. Part 2. Impact of disease states on functionality.高密度脂蛋白。第2部分。疾病状态对功能的影响。
Am J Prev Cardiol. 2025 Aug 7;23:101073. doi: 10.1016/j.ajpc.2025.101073. eCollection 2025 Sep.
2
HDL proteome: from its characterization to quantitative measurements in particle subspecies and functional associations.高密度脂蛋白蛋白质组:从其特征到颗粒亚群中的定量测量及功能关联
Expert Rev Proteomics. 2025 Jul;22(7):273-286. doi: 10.1080/14789450.2025.2534397. Epub 2025 Jul 22.
3
A Multi-Omics Framework for Decoding Disease Mechanisms: Insights From Methylmalonic Aciduria.一种用于解码疾病机制的多组学框架:来自甲基丙二酸血症的见解。
Mol Cell Proteomics. 2025 May 26;24(7):100998. doi: 10.1016/j.mcpro.2025.100998.
4
Association of total cholesterol to high-density lipoprotein cholesterol ratio with diabetes risk: a retrospective study of Chinese individuals.总胆固醇与高密度脂蛋白胆固醇比值与糖尿病风险的关联:一项针对中国人群的回顾性研究
Sci Rep. 2025 May 9;15(1):16261. doi: 10.1038/s41598-025-87277-0.
5
High-Density Lipoprotein in Patients with Diabetic Kidney Disease: Friend or Foe?糖尿病肾病患者中的高密度脂蛋白:是友还是敌?
Int J Mol Sci. 2025 Feb 16;26(4):1683. doi: 10.3390/ijms26041683.
6
Inverse relationship between circulating sphingosine-1-phosphate and precursor species and coronary artery calcification score in type 2 diabetes.2型糖尿病患者循环中鞘氨醇-1-磷酸及其前体物质与冠状动脉钙化评分之间的负相关关系。
Cardiovasc Diabetol. 2025 Feb 21;24(1):85. doi: 10.1186/s12933-025-02624-9.
7
Increased pro-SFTPB in HDL promotes the pro-inflammatory transition of HDL and represents a sign of poor prognosis in ARDS patients.高密度脂蛋白(HDL)中前表面活性蛋白B(pro-SFTPB)增加会促进HDL的促炎转变,这是急性呼吸窘迫综合征(ARDS)患者预后不良的一个迹象。
J Transl Med. 2025 Jan 16;23(1):75. doi: 10.1186/s12967-025-06100-6.
8
Emerging Biomarkers and Determinants of Lipoprotein Profiles to Predict CVD Risk: Implications for Precision Nutrition.用于预测心血管疾病风险的脂蛋白谱的新兴生物标志物和决定因素:对精准营养的启示。
Nutrients. 2024 Dec 27;17(1):42. doi: 10.3390/nu17010042.
9
High-Density Lipoprotein Lipid and Protein Cargo and Cholesterol Efflux Capacity Before and After Bariatric Surgery.减肥手术前后高密度脂蛋白的脂质、蛋白质成分及胆固醇流出能力
Arterioscler Thromb Vasc Biol. 2025 Feb;45(2):e48-e62. doi: 10.1161/ATVBAHA.124.321686. Epub 2025 Jan 2.
10
Analysis of uric acid and high-density lipoprotein levels in refractory posner-schlossman syndrome patients: a matched case-control study by the propensity score.难治性波斯纳-施洛斯曼综合征患者尿酸和高密度脂蛋白水平分析:一项倾向评分匹配病例对照研究
BMC Ophthalmol. 2024 Dec 23;24(1):545. doi: 10.1186/s12886-024-03814-x.

本文引用的文献

1
ApoF knockdown increases cholesteryl ester transfer to LDL and impairs cholesterol clearance in fat-fed hamsters.载脂蛋白 F 敲低增加了胆固醇酯向 LDL 的转移,并损害了高脂肪饮食喂养的仓鼠的胆固醇清除。
J Lipid Res. 2019 Nov;60(11):1868-1879. doi: 10.1194/jlr.RA119000171. Epub 2019 Sep 11.
2
Large-scale lipidomics identifies associations between plasma sphingolipids and T2DM incidence.大规模脂质组学鉴定出血浆神经酰胺与 T2DM 发病之间的关联。
JCI Insight. 2019 Jun 4;5(13):126925. doi: 10.1172/jci.insight.126925.
3
HDL Phospholipids, but Not Cholesterol Distinguish Acute Coronary Syndrome From Stable Coronary Artery Disease.高密度脂蛋白磷脂,但不是胆固醇,可区分急性冠状动脉综合征与稳定型冠状动脉疾病。
J Am Heart Assoc. 2019 Jun 4;8(11):e011792. doi: 10.1161/JAHA.118.011792.
4
From HDL-cholesterol to HDL-function: cholesterol efflux capacity determinants.从高密度脂蛋白胆固醇到高密度脂蛋白功能:胆固醇流出能力的决定因素。
Curr Opin Lipidol. 2019 Apr;30(2):101-107. doi: 10.1097/MOL.0000000000000589.
5
Genetic control of the mouse HDL proteome defines HDL traits, function, and heterogeneity.遗传控制小鼠 HDL 蛋白质组定义了 HDL 特征、功能和异质性。
J Lipid Res. 2019 Mar;60(3):594-608. doi: 10.1194/jlr.M090555. Epub 2019 Jan 8.
6
Plasma levels of apolipoproteins C-III, A-IV, and E are independently associated with stable atherosclerotic cardiovascular disease.载脂蛋白 C-III、A-IV 和 E 的血浆水平与稳定的动脉粥样硬化性心血管疾病独立相关。
Atherosclerosis. 2019 Feb;281:17-24. doi: 10.1016/j.atherosclerosis.2018.11.006. Epub 2018 Nov 9.
7
Development and Validation of Apolipoprotein AI-Associated Lipoprotein Proteome Panel for the Prediction of Cholesterol Efflux Capacity and Coronary Artery Disease.载脂蛋白 AI 相关脂蛋白蛋白质组面板的开发和验证用于预测胆固醇流出能力和冠心病。
Clin Chem. 2019 Feb;65(2):282-290. doi: 10.1373/clinchem.2018.291922. Epub 2018 Nov 21.
8
Impact of glycosylphosphatidylinositol-specific phospholipase D on hepatic diacylglycerol accumulation, steatosis, and insulin resistance in diet-induced obesity.糖基磷脂酰肌醇特异性磷脂酶 D 对饮食诱导肥胖大鼠肝二酰基甘油积聚、脂肪变性和胰岛素抵抗的影响。
Am J Physiol Endocrinol Metab. 2019 Feb 1;316(2):E239-E250. doi: 10.1152/ajpendo.00319.2018. Epub 2018 Nov 20.
9
Mendelian randomization reveals unexpected effects of CETP on the lipoprotein profile.孟德尔随机化揭示了 CETP 对脂蛋白谱的意外影响。
Eur J Hum Genet. 2019 Mar;27(3):422-431. doi: 10.1038/s41431-018-0301-5. Epub 2018 Nov 12.
10
Variants at the APOE /C1/C2/C4 Locus Modulate Cholesterol Efflux Capacity Independently of High-Density Lipoprotein Cholesterol.载脂蛋白 E/ C1/ C2/ C4 基因座的变异独立于高密度脂蛋白胆固醇调节胆固醇外排能力。
J Am Heart Assoc. 2018 Aug 21;7(16):e009545. doi: 10.1161/JAHA.118.009545.